DySISmedical is a medical device company that designs, develops, manufactures and markets imaging systems that facilitate the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DySISmedical assists medical practitioners to improve patient care by incorporating advanced biophotonics and optical molecular imaging technologies that assist in early detection, diagnosis and monitoring.
- 3 April 2012
- Draft Guidance from NICE
- 31 March 2012
- Collaboration with University of Karolinska
- 28 March 2012
- DySIS Achieves Clinical and Cost Benefits




